rs370616818

Variant summary

Our verdict is Likely benign. The variant received -6 ACMG points: 0P and 6B. BP6BP7BS2

The NM_001384474.1(LOXHD1):​c.3024C>T​(p.Val1008Val) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00162 in 1,270,194 control chromosomes in the GnomAD database, including 3 homozygotes. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. V1008V) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0013 ( 0 hom., cov: 30)
Exomes 𝑓: 0.0016 ( 3 hom. )

Consequence

LOXHD1
NM_001384474.1 synonymous

Scores

2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:7

Conservation

PhyloP100: -0.774

Publications

1 publications found
Variant links:
Genes affected
LOXHD1 (HGNC:26521): (lipoxygenase homology PLAT domains 1) This gene encodes a highly conserved protein consisting entirely of PLAT (polycystin/lipoxygenase/alpha-toxin) domains, thought to be involved in targeting proteins to the plasma membrane. Studies in mice show that this gene is expressed in the mechanosensory hair cells in the inner ear, and mutations in this gene lead to auditory defects, indicating that this gene is essential for normal hair cell function. Screening of human families segregating deafness identified a mutation in this gene which causes DFNB77, a progressive form of autosomal-recessive nonsyndromic hearing loss (ARNSHL). Alternatively spliced transcript variants encoding different isoforms have been noted for this gene. [provided by RefSeq, Mar 2010]
LOXHD1 Gene-Disease associations (from GenCC):
  • autosomal recessive nonsyndromic hearing loss 77
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, PanelApp Australia, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • nonsyndromic genetic hearing loss
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • hearing loss, autosomal recessive
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • Fuchs' endothelial dystrophy
    Inheritance: AD Classification: LIMITED Submitted by: Illumina

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -6 ACMG points.

BP6
Variant 18-46560120-G-A is Benign according to our data. Variant chr18-46560120-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 227515.
BP7
Synonymous conserved (PhyloP=-0.774 with no splicing effect.
BS2
High Homozygotes in GnomAdExome4 at 3 AD,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
LOXHD1NM_001384474.1 linkc.3024C>T p.Val1008Val synonymous_variant Exon 19 of 41 ENST00000642948.1 NP_001371403.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
LOXHD1ENST00000642948.1 linkc.3024C>T p.Val1008Val synonymous_variant Exon 19 of 41 NM_001384474.1 ENSP00000496347.1 A0A2R8Y7K4
LOXHD1ENST00000536736.5 linkc.3024C>T p.Val1008Val synonymous_variant Exon 19 of 40 5 ENSP00000444586.1 F5GZB4
LOXHD1ENST00000335730.6 linkn.2337C>T non_coding_transcript_exon_variant Exon 12 of 27 2
LOXHD1ENST00000441551.6 linkc.2599-2631C>T intron_variant Intron 18 of 38 5 ENSP00000387621.2 Q8IVV2-1

Frequencies

GnomAD3 genomes
AF:
0.00132
AC:
159
AN:
120512
Hom.:
0
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.000471
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000576
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000292
Gnomad FIN
AF:
0.00326
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00193
Gnomad OTH
AF:
0.00120
GnomAD2 exomes
AF:
0.000990
AC:
156
AN:
157646
AF XY:
0.00113
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000364
Gnomad ASJ exome
AF:
0.000118
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00131
Gnomad NFE exome
AF:
0.00202
Gnomad OTH exome
AF:
0.000449
GnomAD4 exome
AF:
0.00165
AC:
1894
AN:
1149632
Hom.:
3
Cov.:
38
AF XY:
0.00166
AC XY:
930
AN XY:
561842
show subpopulations
African (AFR)
AF:
0.000246
AC:
6
AN:
24380
American (AMR)
AF:
0.000461
AC:
13
AN:
28224
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
15960
East Asian (EAS)
AF:
0.00
AC:
0
AN:
13026
South Asian (SAS)
AF:
0.0000260
AC:
2
AN:
76810
European-Finnish (FIN)
AF:
0.00158
AC:
45
AN:
28564
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4384
European-Non Finnish (NFE)
AF:
0.00194
AC:
1778
AN:
916820
Other (OTH)
AF:
0.00121
AC:
50
AN:
41464
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
105
209
314
418
523
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
66
132
198
264
330
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00132
AC:
159
AN:
120562
Hom.:
0
Cov.:
30
AF XY:
0.00138
AC XY:
77
AN XY:
55668
show subpopulations
African (AFR)
AF:
0.000470
AC:
15
AN:
31900
American (AMR)
AF:
0.000574
AC:
5
AN:
8704
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3258
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3532
South Asian (SAS)
AF:
0.000293
AC:
1
AN:
3418
European-Finnish (FIN)
AF:
0.00326
AC:
16
AN:
4908
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
176
European-Non Finnish (NFE)
AF:
0.00193
AC:
120
AN:
62126
Other (OTH)
AF:
0.00119
AC:
2
AN:
1678
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.489
Heterozygous variant carriers
0
9
18
28
37
46
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00152
Hom.:
0
Bravo
AF:
0.000990

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:7
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Autosomal recessive nonsyndromic hearing loss 77 Uncertain:1Benign:2
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -

Nov 03, 2017
Counsyl
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This submission and the accompanying classification are no longer maintained by the submitter. For more information on current observations and classification, please contact variantquestions@myriad.com. -

Dec 17, 2019
Natera, Inc.
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:3
Jun 22, 2018
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 06, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jun 01, 2022
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

LOXHD1: BP4, BP7 -

not specified Benign:1
Aug 18, 2015
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

p.Val1008Val in exon 19 of LOXHD1: This variant is not expected to have clinical significance because it does not alter an amino acid residue, is not located wi thin the splice consensus sequence, and has been identified in 0.4% (5/1210) of Finnish chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broad institute.org; dbSNP rs370616818). -

LOXHD1-related disorder Benign:1
Feb 20, 2019
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.28
CADD
Benign
3.1
DANN
Benign
0.69
PhyloP100
-0.77
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs370616818; hg19: chr18-44140083; API